iShares Nasdaq Biotechnology
(NASDAQ: IBB)
AdChoices
283.62
+7.38
+2.67%
:

Open

278.00

Net Assets

5.77B

Day's Range

277.90-285.23

52 week range

197.44-285.23

Category

Health

Vol (3-Month Avg.)

1.26M

Yield

0.16%

Morningstar Risk

Above Average

AdChoices
Performance
Returns %
Key statistics
  • Composition
  • Performance
  • Top Holdings
  • Key Statistics
Composition
Top Equity Sector Holding
Equity Investment Style
The two dimensions of the Fund Style box measure the average size of companies that have been in the ETF, from the top to bottom, and the average valuation characteristics of the ETF's past stock holdings, from left to right.

PERFORMANCE

  • Total Return %

  • 1 Day

  • 1 Week

  • 1 Month

  • 3 Months

  • 1 Year

  • 3 Years

  • 5 Years

    • IBB

    • -0.78

    • 7.64

    • 1.34

    • 8.96

    • 32.86

    • 41.89

    • 29.05

    • Category(Health)

    • -0.59

    • 4.63

    • -0.79

    • 3.91

    • 23.67

    • 27.92

    • 21.98

    • Rank in Category

    • 65

    • 1

    • 15

    • 15

    • 15

    • 1

    • 7

    MORNINGSTAR RATING

    • Years

    • Return

    • Risk

    • Rating

      • 3 Years

      • High

      • Above Average

      • ★★★★★
      • 5 Years

      • High

      • Above Average

      • ★★★★★
      • 10 Years

      • Above Average

      • Above Average

      • ★★★★
      • Overall

      • High

      • Above Average

      • ★★★★★

      TOP HOLDINGS

      • Name

      • % Portfolio Weight

      • Shares Held

      • Change

        • Amgen Inc

        • 8.11

        • 3,501,959

        • 104,650

        • Gilead Sciences Inc

        • 7.92

        • 4,537,130

        • 135,590

        • Celgene Corp

        • 7.85

        • 5,136,878

        • 153,517

        • Regeneron Pharmaceuticals Inc

        • 7.76

        • 1,210,700

        • 36,179

        • Biogen Idec Inc

        • 7.56

        • 1,422,890

        • 42,523

        • Vertex Pharmaceuticals Inc

        • 4.63

        • 2,608,267

        • 77,948

        • Mylan Inc

        • 4.28

        • 4,995,590

        • 149,292

        • Alexion Pharmaceuticals Inc

        • 4.12

        • 1,441,651

        • 43,082

        • Illumina Inc

        • 3.89

        • 1,360,704

        • 40,664

        • Biomarin Pharmaceutical Inc

        • 2.40

        • 1,964,800

        • 58,721

        CATEGORY

        • Name

        • IBB

        • Category

          • Avg. Market Cap USD (M)

          • 16,648.18

          • 27,214.31

          • Expense Ratio

          • 0.48%

          • 0.44%

          • Net Assets

          • 5.77B

          • 1.06B

          • Price/Prospective Earnings

          • 29.64

          • 21.83

          • Price/Book

          • 6.62

          • 4.82

          • Price/Sales

          • 7.22

          • 3.25

          • Price/Cash Flow

          • 15.90

          • 19.29

          • Dividend Yield

          • 0.22%

          • 0.22

          Profile

          Name of Issuer

          iShares

          Expenses

          0.48%

          The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by the NASDAQ OMX Group, Inc. The fund is non-diversified.

          Inception

          2/5/2001